The Kakimizu complex of a link by Banks, JE

What are the effects of adding bupropion or fluoxetine to other treatments compared with using other treatments alone for people trying to quit smoking? by Livingstone-Banks, JE

How does bupropion compare with placebo for promoting smoking cessation in adolescents and adults? by Livingstone-Banks, JE

How does bupropion compare with varenicline or nicotine replacement therapies (NRTs) for promoting smoking cessation in adolescents and adults? by Livingstone-Banks, JE

Methodological inadequacies in Glantz et al: ‘high’ risk of bias and ‘low’ certainty of evidence by Hartmann-Boyce, J, Cook, S, Livingstone-Banks, JE

Treatment of tobacco smoking: A review by Rigotti, NA, Kruse, GR, Livingstone-Banks, JE, Hartmann-Boyce, J

Mindfulness for smoking cessation by Jackson, S, Brown, J, Norris, E, Livingstone-Banks, JE, Hayes, E, Lindson, N

Interventions for smokeless tobacco use cessation by Livingstone-Banks, JE, Siddiqui, F, Croucher, R, Mehrotra, R, Vidyasagaran, A, Siddiqi, K

Systematic reviews should consider effects from both the population and the individual perspective by Verbeek, J, Hoving, J, Boschman, J, Chong, L-Y, Livingstone-Banks, JE, Bero, L

Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation by Theodoulou, A, Chepkin, SC, Ye, W, Fanshawe, TR, Bullen, C, Hartmann-Boyce, J, Livingstone-Banks, JE, Hajizadeh, A, Lindson, N